Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
ResMed Inc. logo
RMD.AX
ResMed Inc.
06:10:08
26.68 A$
0.0000 (%0.00)
Previous Close: 26.5
Day Low₺26.57
Day High₺26.87
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

RMD.AX: ResMed Inc. Financials

ResMed Inc. Income Statement

Total revenue
Net income
Gross margin TTM
59.36%
Operating margin TTM
32.75%
Net profit margin TTM
27.22%
Return on investment TTM
23.47%
Period end30/06/202530/06/202430/06/202330/06/2022
Total revenue5,146,327,0004,685,297,0004,222,993,0003,578,127,000
Operating income1,685,363,0001,319,893,0001,131,871,0001,000,286,000
Net income1,400,723,0001,020,951,000897,556,000779,437,000

All line items

Line item30/06/202530/06/202430/06/202330/06/2022
Total revenue5,146,327,0004,685,297,0004,222,993,0003,578,127,000
Cost of revenue2,091,357,0002,029,994,0001,867,331,0001,553,816,000
Gross profit3,054,970,0002,655,303,0002,355,662,0002,024,311,000
Research and development expenses331,284,000307,525,000287,642,000253,575,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses991,019,000917,136,000874,003,000739,372,000
Other expenses47,304,000110,749,000-5,712,00031,078,000
Operating expenses1,369,607,0001,335,410,0001,203,665,0001,024,025,000
Cost and expenses3,460,964,0003,365,404,0003,070,996,0002,577,841,000
Net interest income4,114,000-45,708,000-47,379,000-22,312,000
Interest income4,114,000000
Interest expense19,469,42845,708,00047,379,00022,312,000
Depreciation and amortization235,811,000216,209,000196,522,000193,841,000
EBITDA1,923,205,0001,533,543,0001,358,801,0001,176,636,000
EBIT1,687,394,0001,310,506,0001,162,279,000982,795,000
Non-operating income (excl. interest)-2,031,0009,387,000-30,408,00017,491,000
Operating income1,685,363,0001,319,893,0001,131,871,0001,000,286,000
Total other income/expenses (net)-7,797,000-55,095,000-30,207,000-39,803,000
Income before tax1,677,566,0001,264,798,0001,101,664,000960,483,000
Income tax expense276,843,000243,847,000204,108,000181,046,000
Net income from continuing operations1,400,723,0001,020,951,000897,556,000779,437,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income1,400,723,0001,020,951,000897,556,000779,437,000
Net income deductions0000
Bottom line net income1,400,723,0001,020,951,000897,556,000779,437,000
EPS0.96290.70660.60380.5059
Diluted EPS0.95880.7040.60090.5025
Weighted average shares outstanding1,467,160,0001,470,210,0001,467,650,0001,460,660,000
Weighted average diluted shares outstanding1,473,400,0001,475,500,0001,474,550,0001,470,430,000

ResMed Inc. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
658,392,000%
Total debt / assets MRQ
—
Period end30/06/202530/06/202430/06/202330/06/2022
Total assets8,174,391,0006,872,394,0006,751,708,0005,095,853,000
Total liabilities2,206,532,0002,008,351,0002,621,805,0001,735,102,000
Total equity5,967,859,0004,864,043,0004,129,903,0003,360,751,000

All line items

Line item30/06/202530/06/202430/06/202330/06/2022
Cash and cash equivalents1,209,450,000238,361,000227,891,000273,710,000
Short-term investments0000
Cash and short-term investments1,209,450,000238,361,000227,891,000273,710,000
Net receivables990,667,000837,275,000704,909,000575,950,000
Accounts receivable939,492,000837,275,000704,909,000575,950,000
Other receivables51,175,000000
Inventory927,711,000822,250,000998,012,000743,910,000
Prepaid expenses213,279,000279,821,000257,093,000206,643,000
Other current assets164,498,000180,012,000179,925,000131,265,000
Total current assets3,505,605,0002,357,719,0002,367,830,0001,931,478,000
Property, plant and equipment (net)718,287,000699,146,000665,811,000630,495,000
Goodwill3,046,680,0002,842,055,0002,770,299,0001,936,442,000
Intangible assets464,861,000485,904,000552,341,000345,944,000
Goodwill and intangible assets3,511,541,0003,327,959,0003,322,640,0002,282,386,000
Long-term investments129,752,057169,766,000-132,974,000-251,494,000
Tax assets253,119,000203,569,000132,974,000251,494,000
Other non-current assets185,839,000114,235,000395,427,000251,494,000
Total non-current assets4,668,786,0004,514,675,0004,383,878,0003,164,375,000
Other assets0000
Total assets8,174,391,0006,872,394,0006,751,708,0005,095,853,000
Total payables446,015,000237,728,000150,756,000159,245,000
Accounts payable278,157,000237,728,000150,756,000159,245,000
Other payables167,858,000000
Accrued expenses363,974,000223,862,000220,785,000194,736,000
Short-term debt9,900,00035,178,00031,821,00031,772,000
Capital lease obligations (current)30,506,00025,278,00021,919,00021,856,000
Tax payables167,858,000107,517,00072,224,00044,893,000
Deferred revenue166,030,000152,554,000138,072,000108,667,000
Other current liabilities2,695,000236,055,000195,180,000173,023,000
Total current liabilities1,019,120,000910,655,000758,533,000689,299,000
Long-term debt658,392,000697,313,0001,431,234,000765,325,000
Capital lease obligations (non-current)153,015,000141,444,000116,853,000120,453,000
Deferred revenue (non-current)156,803,000137,343,000119,186,00095,455,000
Deferred tax liabilities (non-current)77,682,00079,339,00090,650,0009,714,000
Other non-current liabilities141,520,00042,257,000105,349,00054,856,000
Total non-current liabilities1,187,412,0001,097,696,0001,863,272,0001,045,803,000
Other liabilities0000
Capital lease obligations183,521,000166,722,000138,772,000142,309,000
Total liabilities2,206,532,0002,008,351,0002,621,805,0001,735,102,000
Treasury stock-2,073,292,000-1,773,267,000-1,623,256,000-1,623,256,000
Preferred stock0000
Common stock761,000588,000588,000586,000
Retained earnings6,081,490,0004,991,647,0004,253,016,0003,613,736,000
Additional paid-in capital2,033,599,0001,896,604,0001,772,083,0001,682,432,000
Accumulated other comprehensive income/loss-74,699,000-251,529,000-272,528,000-312,747,000
Other stockholders' equity0000
Total stockholders' equity5,967,859,0004,864,043,0004,129,903,0003,360,751,000
Total equity5,967,859,0004,864,043,0004,129,903,0003,360,751,000
Minority interest0000
Total liabilities and total equity8,174,391,0006,872,394,0006,751,708,0005,095,853,000
Total investments149,710,860169,766,000-132,974,000-251,494,000
Total debt851,813,000899,213,0001,579,908,000917,550,000
Net debt-357,637,000660,852,0001,352,017,000643,840,000

ResMed Inc. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end30/06/202530/06/202430/06/202330/06/2022
Cash from operations1,751,588,0001,401,260,000693,299,000351,147,000
Cash from investing-200,045,000-269,784,000-1,159,845,000-229,918,000
Cash from financing-606,253,000-1,119,287,000422,874,000-128,363,000
Net change in cash971,089,00010,470,000-45,819,000-21,568,000

All line items

Line item30/06/202530/06/202430/06/202330/06/2022
Net income1,400,723,0001,020,951,000897,556,000779,437,000
Depreciation and amortization235,811,000216,209,000197,562,000193,841,000
Deferred income tax00216,0000
Stock-based compensation91,661,00080,184,00071,142,00065,257,000
Change in working capital16,738,00044,784,000-462,127,000-708,076,000
Accounts receivable-76,684,000-134,278,000-106,511,00019,346,000
Inventory-80,165,000172,203,000-248,833,000-311,681,000
Accounts payable0031,342,000-247,632,000
Other working capital173,587,000-127,419,000-138,125,000-168,109,000
Other non-cash items6,655,00039,132,000-11,050,00020,688,000
Net cash from operating activities1,751,588,0001,401,260,000693,299,000351,147,000
Investments in property, plant and equipment-89,865,000-99,460,000-134,000,000-156,036,000
Acquisitions (net)-139,248,000-133,464,000-1,012,749,000-42,784,000
Purchases of investments-6,416,000-22,464,000-32,229,000-37,900,000
Sales/maturities of investments46,261,0001,000,00019,133,0006,802,000
Other investing activities-10,777,000-15,396,00015,196,000-17,176,000
Net cash from investing activities-200,045,000-269,784,000-1,159,845,000-229,918,000
Net debt issuance-40,000,000-730,000,000665,000,000122,000,000
Long-term net debt issuance-40,000,000-730,000,000665,000,000122,000,000
Short-term net debt issuance0000
Net stock issuance-225,586,000-96,917,00049,142,00047,384,000
Net common stock issuance-225,586,000-96,917,00049,142,00047,384,000
Common stock issuance74,439,00053,094,00049,142,00047,384,000
Common stock repurchased-300,025,000-150,011,00000
Net preferred stock issuance0000
Net dividends paid-310,880,000-282,320,000-258,276,000-245,341,000
Common dividends paid-310,880,000-282,320,000-258,276,000-245,341,000
Preferred dividends paid0000
Other financing activities-29,787,000-10,050,000-32,992,000-52,406,000
Net cash from financing activities-606,253,000-1,119,287,000422,874,000-128,363,000
Effect of FX changes on cash25,799,000-1,719,000-2,147,000-14,434,000
Net change in cash971,089,00010,470,000-45,819,000-21,568,000
Cash at end of period1,209,450,000238,361,000227,891,000273,710,000
Cash at beginning of period238,361,000227,891,000273,710,000295,278,000
Operating cash flow1,751,588,0001,401,260,000693,299,000351,147,000
Capital expenditure-100,642,000-114,856,000-134,000,000-156,036,000
Free cash flow1,650,946,0001,286,404,000559,299,000195,111,000
Income taxes paid214,013,000278,400,000216,866,000478,120,000
Interest paid28,415,00045,708,00047,379,00022,312,000